|
Volumn 19, Issue 8, 2001, Pages 819-829
|
The cost effectiveness of stratified care in the management of migraine
a b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANALGESIC AGENT;
METOCLOPRAMIDE;
ZOLMITRIPTAN;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE SEVERITY;
HEALTH CARE COST;
HEALTH SERVICE;
HUMAN;
MIGRAINE;
MODEL;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
UNITED KINGDOM;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
MALE;
MIGRAINE DISORDERS;
OXAZOLIDINONES;
RANDOMIZED CONTROLLED TRIALS;
SEROTONIN AGONISTS;
SEVERITY OF ILLNESS INDEX;
TRYPTAMINES;
|
EID: 0034871055
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200119080-00004 Document Type: Article |
Times cited : (33)
|
References (24)
|